Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?Joanne M. Osborne, Graeme P. Young, Carlene Wilson et al.|BMC Public Health|2017Cited by 30
A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer ScreeningErin L. Symonds, Graeme P. Young, Richard Woodman et al.|Cancer Prevention Research|2019Cited by 23
“Rescue” of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test OptionsGraeme P. Young, Erin L. Symonds, Ellen McGrane et al.|Cancer Prevention Research|2021Cited by 20
Can we address cancer disparities in immigrants by improving cancer literacy through English as a second language instruction?Donna Hughes, Carlene Wilson, Janine Chapman et al.|Translational Behavioral Medicine|2018Cited by 4
Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherenceGeraldine Laven‐Law, Graeme P. Young, Jean M. Winter et al.|Journal of Gastroenterology and Hepatology|2024Cited by 4